This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
27 - 29 May, 2026
Congress CenterBasel Switzerland
BOOK NOW
Menu
BOOK NOW

Francesca Zammarchi, PhD
Chief Scientific Officer at Myricx Bio
Speaker

Agenda Sessions

  • From Discovery to Translation: Pre-Clinical Advancement of NMT Inhibitors as a Novel Payload Platform for ADC Development

    , 08:20
    View Session

At this event

Prev
Next
Jan Terje Andersen, Ph.D.
Professor, University of Oslo and Group Leader
Oslo University Hospital

See Francesca at Antibody Engineering & Therapeutics Europe

BOOK NOW